Clinical Trial Update: Phase 1 Study to Determine the Effect of Lenvatinib (E7080) on the Pharmacokinetics of Midazolam in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study investigating how lenvatinib affects the pharmacokinetics of midazolam in patients with advanced solid tumors; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Lenvatinib (lenvatinib)
• Midazolam (Midazolam)

Snippet

Sponsor: Eisai Inc. | Conditions: Tumors | Phase 1 | Status: COMPLETED | Results posted: 2019-08-28